ZAP-70 mRNA expression provides clinically valuable information in early-stage chronic lymphocytic leukemia

Cristina Reinoso-Martín,E. Jantus-Lewintre,C. G. Ballesteros,C. Campos,José Ramón Mayans Ferrer,J. Garcia-conde
DOI: https://doi.org/10.3324/haematol.12710
2008-09-01
Haematologica
Abstract:Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a variable clinical course and overall survival times ranging from months to decades.[1][1] Mutational status of immunoglobulin heavy chain variable region (IGHV) correlates with clinical behavior and is a powerful prognostic factor
What problem does this paper attempt to address?